These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32296422)

  • 1. LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis.
    Klepfish M; Gross T; Vugman M; Afratis NA; Havusha-Laufer S; Brazowski E; Solomonov I; Varol C; Sagi I
    Front Immunol; 2020; 11():480. PubMed ID: 32296422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
    Ikenaga N; Peng ZW; Vaid KA; Liu SB; Yoshida S; Sverdlov DY; Mikels-Vigdal A; Smith V; Schuppan D; Popov YV
    Gut; 2017 Sep; 66(9):1697-1708. PubMed ID: 28073888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
    Schilter H; Findlay AD; Perryman L; Yow TT; Moses J; Zahoor A; Turner CI; Deodhar M; Foot JS; Zhou W; Greco A; Joshi A; Rayner B; Townsend S; Buson A; Jarolimek W
    J Cell Mol Med; 2019 Mar; 23(3):1759-1770. PubMed ID: 30536539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
    Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
    Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice.
    Liu SB; Ikenaga N; Peng ZW; Sverdlov DY; Greenstein A; Smith V; Schuppan D; Popov Y
    FASEB J; 2016 Apr; 30(4):1599-609. PubMed ID: 26700732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.
    Chen W; Yang A; Jia J; Popov YV; Schuppan D; You H
    Hepatology; 2020 Aug; 72(2):729-741. PubMed ID: 32176358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway.
    Cheng F; Yang F; Wang Y; Zhou J; Qian H; Yan Y
    J Nanobiotechnology; 2023 Jun; 21(1):195. PubMed ID: 37328872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.
    El Hajj EC; El Hajj MC; Ninh VK; Gardner JD
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H463-H473. PubMed ID: 29775412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis.
    Geervliet E; Moreno S; Baiamonte L; Booijink R; Boye S; Wang P; Voit B; Lederer A; Appelhans D; Bansal R
    J Control Release; 2021 Apr; 332():594-607. PubMed ID: 33737203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes from hypoxic endothelial cells have increased collagen crosslinking activity through up-regulation of lysyl oxidase-like 2.
    de Jong OG; van Balkom BW; Gremmels H; Verhaar MC
    J Cell Mol Med; 2016 Feb; 20(2):342-50. PubMed ID: 26612622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withaferin A reverses bile duct ligation-induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signaling.
    Sayed N; Khurana A; Saifi MA; Singh M; Godugu C
    Biofactors; 2019 Nov; 45(6):959-974. PubMed ID: 31336025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin.
    Schmelzer CEH; Heinz A; Troilo H; Lockhart-Cairns MP; Jowitt TA; Marchand MF; Bidault L; Bignon M; Hedtke T; Barret A; McConnell JC; Sherratt MJ; Germain S; Hulmes DJS; Baldock C; Muller L
    FASEB J; 2019 Apr; 33(4):5468-5481. PubMed ID: 30676771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse.
    Nguyen LT; Saad S; Shi Y; Wang R; Chou ASY; Gill A; Yao Y; Jarolimek W; Pollock CA
    Sci Rep; 2021 Jun; 11(1):12437. PubMed ID: 34127702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy.
    Stangenberg S; Saad S; Schilter HC; Zaky A; Gill A; Pollock CA; Wong MG
    Sci Rep; 2018 Jun; 8(1):9423. PubMed ID: 29930330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix.
    Grossman M; Ben-Chetrit N; Zhuravlev A; Afik R; Bassat E; Solomonov I; Yarden Y; Sagi I
    Cancer Res; 2016 Jul; 76(14):4249-58. PubMed ID: 27221706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking.
    Zhao W; Yang A; Chen W; Wang P; Liu T; Cong M; Xu A; Yan X; Jia J; You H
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1129-1137. PubMed ID: 29366776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver.
    Sojoodi M; Erstad DJ; Barrett SC; Salloum S; Zhu S; Qian T; Colon S; Gale EM; Jordan VC; Wang Y; Li S; Ataeinia B; Jalilifiroozinezhad S; Lanuti M; Zukerberg L; Caravan P; Hoshida Y; Chung RT; Bhave G; Lauer GM; Fuchs BC; Tanabe KK
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1483-1509. PubMed ID: 35093588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
    Kumagai K; Tabu K; Sasaki F; Takami Y; Morinaga Y; Mawatari S; Hashimoto S; Tanoue S; Kanmura S; Tamai T; Moriuchi A; Uto H; Tsubouchi H; Ido A
    PLoS One; 2015; 10(11):e0143413. PubMed ID: 26599547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.